|
Volumn 61, Issue 1, 2012, Pages 219-220
|
Re: Ten-year survival analysis for renal carcinoma patients treated with an autologous tumour lysate vaccine in an adjuvant setting
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA INTERFERON;
AMINOLEVULINIC ACID;
AMINOLEVULINIC ACID HEXYL ESTER;
AUTOLOGOUS RENAL CELL TUMOR VACCINE;
BCG VACCINE;
CANCER VACCINE;
CYTOKINE;
GAMMA INTERFERON;
INTERLEUKIN 2;
RENIALE;
UNCLASSIFIED DRUG;
ADVERSE OUTCOME;
BLADDER TUMOR;
CANCER IMMUNOTHERAPY;
CLINICAL PROTOCOL;
CRYOTHERAPY;
EVIDENCE BASED MEDICINE;
FOLLOW UP;
HUMAN;
KIDNEY CARCINOMA;
MAJOR CLINICAL STUDY;
NEPHRECTOMY;
OVERALL SURVIVAL;
PHOTODYNAMIC THERAPY;
PRIORITY JOURNAL;
PROGRESSION FREE SURVIVAL;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
SHORT SURVEY;
TREATMENT OUTCOME;
TUMOR CELL;
UNSPECIFIED SIDE EFFECT;
VACCINATION;
CANCER VACCINES;
CARCINOMA, RENAL CELL;
FEMALE;
HUMANS;
KIDNEY NEOPLASMS;
MALE;
|
EID: 82255177141
PISSN: 03022838
EISSN: 18737560
Source Type: Journal
DOI: 10.1016/j.eururo.2011.10.014 Document Type: Short Survey |
Times cited : (4)
|
References (9)
|